Treatment Preferences for Chronic Low Back Pain: Views of Veterans and Their Providers

Overview

Journal J Pain Res

Publisher Dove Medical Press

Date 2021 Feb 4

PMID 33536780

Citations 6

Authors

Ilana Belitskaya-Levy

J David Clark

Mei-Chiung Shih

Matthew J Bair

Affiliations

Soon will be listed here.

Abstract

Purpose: This study was conducted to characterize chronic low back pain (cLBP) and to identify treatment histories and preferences for cLBP management among Veterans and primary care providers within the Veterans Affairs (VA) healthcare system.

Participants And Methods: Veterans with cLBP from five geographically diverse VA medical centers were identified using International Classification of Diseases (ICD) 9 and 10 codes from VA administrative data as were primary care providers at these same sites. From these data, Veterans (200/per site) and providers (160/per site) were selected and mailed surveys. Open-ended interview data were collected from a subset of Veterans and providers.

Results: In total, 235 Veterans and 67 providers returned completed surveys. More than 80% of the Veteran respondents had daily back pain for more than 1 year. Most Veterans had tried several treatments for their pain with medications and physical therapy being the most commonly used. Veterans and providers had similar attitudes towards many cLBP treatments with the exception of psychological therapies that were more favored by providers. Open-ended interview data showed that Veterans and providers emphasized the need for multi-component approaches to treatment.

Conclusion: Among Veterans, cLBP is typically of sustained duration, is relatively severe, and also interferes significantly with normal functioning. Veterans are experienced with respect to treatments and had similar attitudes towards many cLBP treatments as their providers, especially tailored approaches.

Citing Articles

The implementation of a pain navigator program in the department of Veterans Affairs' (VA) health care systems: a cluster randomized pragmatic clinical trial.

France C, Cook C, Coffman C, Tumminello C, Choate A, George S Pain Med. 2024; 25(Supplement_1):S83-S90.

PMID: 39514873 PMC: 11548858. DOI: 10.1093/pm/pnae074.

Aucubin Alleviates Intervertebral Disc Degeneration by Repressing NF-κB-NLRP3 Inflammasome Activation in Endplate Chondrocytes.

Zou K, Ying J, Xu H, Zeng Q, Huang H, Chen W J Inflamm Res. 2023; 16:5899-5913.

PMID: 38084106 PMC: 10710784. DOI: 10.2147/JIR.S439981.

Updates on Pathophysiology of Discogenic Back Pain.

Jha R, Bernstock J, Chalif J, Hoffman S, Gupta S, Guo H J Clin Med. 2023; 12(21).

PMID: 37959372 PMC: 10647359. DOI: 10.3390/jcm12216907.

Discogenic Low Back Pain: Anatomy, Pathophysiology and Treatments of Intervertebral Disc Degeneration.

Mohd Isa I, Teoh S, Mohd Nor N, Mokhtar S Int J Mol Sci. 2023; 24(1).

PMID: 36613651 PMC: 9820240. DOI: 10.3390/ijms24010208.

Intervertebral Disc Degeneration: Biomaterials and Tissue Engineering Strategies toward Precision Medicine.

Mohd Isa I, Mokhtar S, Abbah S, Fauzi M, Devitt A, Pandit A Adv Healthc Mater. 2022; 11(13):e2102530.

PMID: 35373924 PMC: 11469247. DOI: 10.1002/adhm.202102530.

References

Jacobs N, Montebello M, Monds L, Lintzeris N . Survey of Australian psychiatrists' and psychiatry trainees' knowledge about and attitudes towards medicinal cannabinoids. Australas Psychiatry. 2018; 27(1):80-85. DOI: 10.1177/1039856218803675. View

Nicholas M, Costa D, Blanchard M, Tardif H, Asghari A, Blyth F . Normative data for common pain measures in chronic pain clinic populations: closing a gap for clinicians and researchers. Pain. 2019; 160(5):1156-1165. DOI: 10.1097/j.pain.0000000000001496. View

Bieber C, Muller K, Blumenstiel K, Schneider A, Richter A, Wilke S . Long-term effects of a shared decision-making intervention on physician-patient interaction and outcome in fibromyalgia. A qualitative and quantitative 1 year follow-up of a randomized controlled trial. Patient Educ Couns. 2006; 63(3):357-66. DOI: 10.1016/j.pec.2006.05.003. View

Veizi E, Hayek S . Interventional therapies for chronic low back pain. Neuromodulation. 2014; 17 Suppl 2:31-45. DOI: 10.1111/ner.12250. View

Clark J . Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage. 2002; 23(2):131-7. DOI: 10.1016/s0885-3924(01)00396-7. View

Yu W, Ravelo A, Wagner T, Phibbs C, Bhandari A, Chen S . Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev. 2004; 60(3 Suppl):146S-167S. DOI: 10.1177/1077558703257000. View

Foster N, Anema J, Cherkin D, Chou R, Cohen S, Gross D . Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018; 391(10137):2368-2383. DOI: 10.1016/S0140-6736(18)30489-6. View

Krebs E, Lorenz K, Bair M, Damush T, Wu J, Sutherland J . Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med. 2009; 24(6):733-8. PMC: 2686775. DOI: 10.1007/s11606-009-0981-1. View

Cooke A, Knight K, Miaskowski C . Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care. Int J Drug Policy. 2018; 63:23-28. PMC: 6353665. DOI: 10.1016/j.drugpo.2018.09.002. View

10.

Meucci R, Fassa A, Faria N . Prevalence of chronic low back pain: systematic review. Rev Saude Publica. 2015; 49. PMC: 4603263. DOI: 10.1590/S0034-8910.2015049005874. View

11.

Von Korff M, Scher A, Helmick C, Carter-Pokras O, Dodick D, Goulet J . United States National Pain Strategy for Population Research: Concepts, Definitions, and Pilot Data. J Pain. 2016; 17(10):1068-1080. DOI: 10.1016/j.jpain.2016.06.009. View

12.

Sox H, Greenfield S . Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. 2009; 151(3):203-5. DOI: 10.7326/0003-4819-151-3-200908040-00125. View

13.

Sullivan M, Leigh J, Gaster B . Brief report: Training internists in shared decision making about chronic opioid treatment for noncancer pain. J Gen Intern Med. 2006; 21(4):360-2. PMC: 1484730. DOI: 10.1111/j.1525-1497.2006.00352.x. View

14.

. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1789-1858. PMC: 6227754. DOI: 10.1016/S0140-6736(18)32279-7. View

15.

Katz J . Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg Am. 2006; 88 Suppl 2:21-4. DOI: 10.2106/JBJS.E.01273. View

16.

Kerns R, Otis J, Rosenberg R, Reid M . Veterans' reports of pain and associations with ratings of health, health-risk behaviors, affective distress, and use of the healthcare system. J Rehabil Res Dev. 2004; 40(5):371-9. DOI: 10.1682/jrrd.2003.09.0371. View

17.

Smith S, Gewandter J, Kitt R, Markman J, Vaughan J, Cowan P . Participant Preferences for Pharmacologic Chronic Pain Treatment Trial Characteristics: An ACTTION Adaptive Choice-Based Conjoint Study. J Pain. 2016; 17(11):1198-1206. DOI: 10.1016/j.jpain.2016.07.008. View

18.

Morley S, Williams A . New Developments in the Psychological Management of Chronic Pain. Can J Psychiatry. 2015; 60(4):168-75. PMC: 4459243. DOI: 10.1177/070674371506000403. View

19.

Qaseem A, Wilt T, McLean R, Forciea M, Denberg T, Barry M . Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017; 166(7):514-530. DOI: 10.7326/M16-2367. View

20.

Chou R, Deyo R, Friedly J, Skelly A, Hashimoto R, Weimer M . Nonpharmacologic Therapies for Low Back Pain: A Systematic Review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017; 166(7):493-505. DOI: 10.7326/M16-2459. View